TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biolin Scientific AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 111,700 | 104,285 | 94,891 |
Financial expenses | 438 | 238 | 431 |
Earnings before taxes | 19,651 | 14,698 | 12,855 |
EBITDA | 24,612 | 20,414 | 19,986 |
Total assets | 115,321 | 102,221 | 113,979 |
Current assets | 34,409 | 25,023 | 33,325 |
Current liabilities | 26,443 | 26,581 | 21,936 |
Equity capital | 88,099 | 74,893 | 70,015 |
- share capital | 25,143 | 25,922 | 27,846 |
Employees (average) | 21 | 23 | 19 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 76.4% | 73.3% | 61.4% |
Turnover per employee | 5,319 | 4,534 | 4,994 |
Profit as a percentage of turnover | 17.6% | 14.1% | 13.5% |
Return on assets (ROA) | 17.4% | 14.6% | 11.7% |
Current ratio | 130.1% | 94.1% | 151.9% |
Return on equity (ROE) | 22.3% | 19.6% | 18.4% |
Change turnover | 10,549 | 15,951 | -24,101 |
Change turnover % | 10% | 18% | -20% |
Chg. No. of employees | -2 | 4 | -1 |
Chg. No. of employees % | -9% | 21% | -5% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.